Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sterile alpha motif domain-containing protein 7 (SAMD7) is a nuclear protein essential for the epigenetic regulation of gene expression in retinal photoreceptor cells. It acts as a transcriptional corepressor by interacting with transcription factors such as Cone-Rod Homeobox (CRX) and rod-specific Nr2e3, recruiting the Polycomb repressive complex 1 (PRC1) to mediate gene silencing through chromatin modification. SAMD7 specifically silences nonrod gene expression in rod photoreceptor cells by promoting H3K27me3 deposition and chromatin compaction, thus defining rod cell identity. Mutations in SAMD7 cause autosomal-recessive macular dystrophy, highlighting its crucial role in human retinal function[1][2][3][5][6]. SAMD7 is primarily expressed in the retina, localized to the nuclei of rods and cones, and the inner nuclear layer of the retina[2][3][5]. There is currently no evidence that SAMD7 is a direct drug target or that drugs interact with this protein.
No drugs act on SAMD7, so mechanisms of drug action targeting it are unavailable.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sterile alpha motif domain-containing protein 7 (SAMD7).